TIAA CREF Investment Management’s Clearside Biomedical CLSD Stock Holding History

TIAA CREF Investment Management’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$66K	Sell	3,186 -13	-0.4%	-$258	﹤0.01%	2982
2018 Q4	$51K	Hold	3,199	–	–	﹤0.01%	2998
2018 Q3	$295K	Sell	3,199 -3,063	-49%	-$364K	﹤0.01%	2893
2018 Q2	$1M	Buy	6,262 +1,946	+45%	+$328K	﹤0.01%	2492
2018 Q1	$695K	Buy	4,316 +452	+12%	+$55.1K	﹤0.01%	2607
2017 Q4	$406K	Buy	3,864 +439	+13%	+$47.1K	﹤0.01%	2860
2017 Q3	$449K	Sell	3,425 -291	-8%	-$35.5K	﹤0.01%	2872
2017 Q2	$508K	Buy	3,716 +2,432	+189%	+$292K	﹤0.01%	2864
2017 Q1	$153K	Buy	1,284 +302	+31%	+$35.6K	﹤0.01%	3020
2016 Q4	$132K	Buy	+982	New	+$246K	﹤0.01%	3067

Other funds holding CLSD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

TIAA CREF Investment Management's CLSD Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Clearside Biomedical (CLSD) stake by 0.41% in Q1 2019, selling an estimated $258 and leaving 3,186 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #2982.

TIAA CREF Investment Management first reported a position in CLSD in Q4 2016 and has held it in 10 quarters since. The position peaked at $1M in Q2 2018. 57 funds tracked by Wall St. Rank hold CLSD as of Q1 2019.

TIAA CREF Investment Management held 3,186 shares of Clearside Biomedical worth $66K as of Q1 2019.
TIAA CREF Investment Management sold 13 Clearside Biomedical shares in Q1 2019, an estimated $258.
Clearside Biomedical made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2982 holding.
TIAA CREF Investment Management first reported a position in Clearside Biomedical in Q4 2016 and has held it in 10 quarters since.
TIAA CREF Investment Management's Clearside Biomedical position peaked at $1M in Q2 2018.
57 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.